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要　旨
　私は2017年９月に千葉大学大学院看護学研究科とUCLAメディカルセンターが行うアメリカの看護
を学ぶ研修に参加した．そこでの私の目的は，UCLAメディカルセンターでの出生前検査の在り方と
職種間連携について学ぶことであった．本著では，日本での出生前検査の現状と異なる三点について
論じる．まず１つめに，UCLAメディカルセンターでは妊娠初期に全妊婦がカリフォルニア州の出生
前スクリーニングプログラムについて情報提供され，ほとんどの妊婦が何らかのスクリーニングや出
生前診断を受けていた．２つめに，アメリカは日本より医療専門職の種類が多く，それぞれの専門性
も高かった．またそれらの専門職は独立して妊婦やその家族に対する意思決定支援を行い，その情報
は電子カルテで他職種に共有され，互いに連携がはかられていた．３つめに，アメリカは対象となる
妊婦の人種や経済的背景，宗教などの個別性が大きかった．カリフォルニア州ではメディカルと呼ば
れる公的な医療保険制度があり，それに認定された低所得世帯はこの制度を利用して，出生前スク
リーニングやそれに付随する支援を無料で受けることができた．またインフォームドコンセントを得
る際に，英語を話さない患者には公的な通訳サービスを用い，自律的な意思決定ができるよう配慮さ
れていた．諸外国と比べ，日本の出生前検査の普及率はとても低い．しかし近年，妊娠中に胎児の情
報を得たいというニーズは増加している．また胎児期に出生前検査によって得られる胎児の状態も増
えている．そのため看護職が出生前検査の情報提供に関わることが求められている．妊婦の出生前検
査に関するインフォームドコンセントや意思決定を支えるには，看護職の更なる役割の高度化や連携
が必要であると考えた．
Key Words： 出生前検査，出生前スクリーニング，UCLA，意思決定支援，医療専門職連携
　　　　　　　　　　　　
千葉大学大学院看護学研究科博士後期課程
Doctoral Course, Chiba University Graduate School of Nursing
千葉大学大学院看護学研究科紀要　第41号
−75−
Ⅰ Introduction
　Over the past 20 years, prenatal screening 
has become widespread in the world１）．In 
Japan, the number of prenatal screening was 
much smaller than in other countries. A survey 
showed prenatal testing （screening followed by 
diagnosis） was performed in fewer than 3% of 
all pregnancies in 2008２）．However, the recent 
availability of Non-Invasive Prenatal Testing 
（NIPT） in 2013 generated a steady increase in 
demand for prenatal testing among Japanese 
pregnant women３）４），which also increased the 
risk of poorly informed decision-making５）６）． 
　Chiba University Graduate School of Nursing 
has performed a Nurse Exchange Program with 
University of California, Los Angeles （UCLA） 
Medical Center since 1993. In 2017, the program 
was held on September 18th to 22nd. It was a 
precious opportunity to learn about how 
prenatal testing was offered in the USA. My 
purpose was to learn about prenatal testing and 
the support to pregnant women and their 
families provided by cooperating healthcare 
professionals in UCLA Medical Center. The 
perinatal Unit Director of nursing selected 
departments at UCLA Medical Center or 
affiliated hospitals for me to compare access to 
prenatal screening or diagnosis in Japan and the 
USA. These institutions are listed in Table 1.
Ⅱ  Findings of offering prenatal screenings 
and diagnoses in UCLA Medical Center
１．Access‌to‌prenatal‌screening‌in‌UCLA‌
Medical‌Center‌and‌Japan
　There were some differences regarding 
prenatal screenings between UCLA Medical 
Center and Japan. 
　The Table 2 shows prenatal testing options in 
UCLA Medical Center. Most pregnant women 
in there accepted screenings from the end of 
the first trimester. The American College of 
Obstetrics and Gynecologists （ACOG） published 
guidelines recommending screening for all 
women regardless of age in 2007７）８）．Then, in 
2009, the California State Genetic Disease 
Branch introduced a state-wide prenatal 
screening program７）．This program aims to 
ensure that prenatal screening services and 
Abstract
　A nurse exchange program between Chiba University Graduate School of Nursing and UCLA 
Medical Center was conducted in September 2017. The purpose of my participation in this 
exchange program was to learn how prenatal screening or diagnosis is offered and how inter-
professional occurs cooperation in UCLA Medical Center. There were three major differences 
between testing in UCLA Medical Center and Japan. First, the implementation rate of prenatal 
screenings in UCLA Medical Center was higher than in Japan. All pregnant women were offered 
the opportunity to enter the program in the California Prenatal Screening Program at the early 
stage of pregnancy. Secondly, the healthcare staff at UCLA Medical Center was generally more 
diverse and specialized professionally when compared to Japan. Each healthcare professional 
supported pregnant women and their families’ decision-making and shared information related to 
prenatal tests were shared among all involved experts by using electronic medical records. Lastly, 
the American population features a broad spectrum of socioeconomic and ethnic backgrounds. The 
California public insurance （Medi-Cal） covers the cost of prenatal screening program for 
registered low income patients. When giving informed consent, standardized translational service 
is used so that pregnant women autonomously make a decision. Although fewer prenatal 
screening or diagnosis is performed in Japan compared to other countries, the number of pregnant 
women requesting these screenings to detect fetal abnormalities in increasing. Furthermore, the 
range of conditions identified by genetic variants during pregnancy is expanding. Finally nurses 
and midwives should become more active in supporting pregnant women’s decision-making. More 
advanced qualification and practical cooperation among Japanese nursing professions are needed 
to support informed decision-making regarding prenatal testing.
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follow-up diagnostic services are available to all 
pregnant women in California. For women with 
screening results indicating a high risk of a 
birth defect, the program provides free follow-
up diagnostic services. Participation in the 
testing and follow-up services is voluntary９）． 
During the early stage of pregnancy, all 
pregnant women were informed about the 
prenatal screening program. Subsequently, 
pregnant women have the right to decline 
participation. Genetic counseling is available to 
women who show high risk of chromosome 
abnormalities such as advanced maternal 
age or family history. Invasive procedures 
（amniocentesis and chorionic villus sampling） 
are covered by public or private insurance９）． 
Low income households have access to state 
insurance Medi-Cal７）10）．Medi-Cal covers medical 
expenses including prenatal screening or 
genetic counseling for high risk patients. For 
others, the cost incurred for genetic counseling 
or prenatal diagnosis varies depending on 
insurance coverage. All pregnant women were 
offered participation in the California Prenatal 
Screening Program. They are able to decide 
which test they choose, using genetic counseling 
or other resources as reference.
　In Japan, there is no governmental law ruling 
availability of prenatal screening or diagnosis. 
As a result, an expert committee including 
members of Japan Society of Obstetrics and 
Gynecology （JSOG） made the decision to not 
recommend the use of maternal serum marker 
screenings11）．Therefore, prenatal screening or 
diagnosis options differ according to areas and 
institutions in Japan. Therefore, not all pregnant 
women are offered prenatal screenings such as 
serum screening or Nuchal Translucency （NT） 
measurement  dur ing  f i r s t  and  second 
trimesters. However ultrasound checkups are 
not considered prenatal genetic screenings, and 
are performed routinely without requiring 
consent12）13）．Regarding the cost, the lack of 
governmental support prevents public or 
Table1. Insititutions visited during the program
Institutions Learning  contents
Ronald Reagan UCLA Medical Center: Outpatient 
clinic, Birth place
Genetic counseling by Genetic Counselor, Prenatal 
check up by CNM＊3
OBGYN＊1  at West Medical （Westwood）: Medi-Cal 
（state insured） accepted
Family planning, STD＊4  treatment, D&C＊5 caring 
and patient education by RN＊6
UCLA Medical Center, Santa Monica: Birth place, High 
risk OB＊2  clinic
High-risk pregnancy care by NP＊7, Maternal Fetal 
Medicine by a physician
＊1OBGYN: Obstetrics and Gynecology, ＊2OB: Obstetrics, ＊3CNM: Certified Nurse-Midwives, 
＊4STD: Sexually Transmitted Disease, ＊5D&C: Dilation and Curettage, ＊6RN: Registered Nurse, 
＊7NP: Nurse Practitioner
Table2.  Prenatal genetic risk assessment and testing options in UCLA  
（Modified after UCLA David Geffen School of Medicine）
GENETIC 
SCREENING 
AND 
TESTING 
OPTIONS
Ultrasound
California Prenatal 
Screening Program
NIPT Diagnostic testing Carrier screening
1st 
Trimester
Nucal 
translucency 
［11-14weeks］
1st Trimester 
Screening 
［11weeks 2days- 
13weeks 6days］
PAPPA-A&HCG1 
Trisomy 21, 18
＞9weeks 
Trisomy 21, 18,
13, Monosomy X, 
Triploidy,
gender
［microdeletions］
Chorionic Villus 
sampling （CVS）
Chromosome analysis, 
Microarray,
-Miscarriage
-Mosaicism
-Cystic fibrosis
-spinal muscular 
atrophy
-Sickle cell
-Thalassemia
-Ashkenazi Jewish 
panel2nd 
Trimester
Complete 
anatomy
［18-22weeks］
2nd Trimester 
Screening 
［15-20 weeks］
AFP, HCG, uE3, INH 
Trisomy 21,18, SLOS, 
Spina bifida
Amniocentesis 
chromosome analysis, 
AF-AFP,
Microarray,
-Miscarriage
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private insurance from covering the expenses 
for prenatal screening or genetic counseling. 
Japanese pregnant women need to pay for their 
own tests if they want to undergo prenatal 
screening, diagnosis or genetic counseling. In 
Japan, prenatal testing is less accessible than at 
UCLA Medical Center. 
２．‌Specialization‌of‌healthcare‌professionals
　In the USA, the diversity of healthcare 
professions is higher than in Japan. For 
example, Registered Nurses （RNs），Nurse 
Practitioners （NPs），Clinical Nurse Specialists 
（CNSs），Certified Nurse Midwives （CNMs） 
commonly collaborated at UCLA Medical 
Center and affi l iated hospitals . Not only 
physicians but also CNMs and NPs can order 
prenatal screenings and tell women the result of 
the tests in case of normal result. In case of 
abnormal result, they can introduce the patient 
to a genetic counsellor, an Obstetrics and 
Gynecology physician or a Maternal-Fetal 
Medic ine （MFM） spec ia l i s t .  Then ,  the 
information about the nature of counseling and 
the test result are shared among all healthcare 
professionals by means of electronic medical 
records. In UCLA, nurses or midwives are able 
to function independently for prenatal checkups, 
patient education, medication, or follow-up of 
surgery .  Rou t ine  procedures ,  such  a s 
examination by interview, measurement of vital 
signs, urine tests, room cleaning and preparation 
before prenatal checkups are usually performed 
by Medical assistants. In Japan, NPs and CNSs 
started in the past several decades, and the 
population is still small. Nurses including NPs 
and CNSs ,  and midwives cannot  order 
screenings nor prescribe a medicine without a 
doctor’s prescription. Japanese NPs and CNSs 
are referred to ‘koudo na kango’ which means 
as ‘advanced nurse’, however their responsibilities 
are no different from those of nurses and 
midwives in practice. They mostly have similar 
duties as American RNs and CNMs, they are 
also in charge of routine procedures usually 
assumed by American Medical assistants. The 
role of each nursing profession is therefore 
more ambiguous in Japan than the USA.
　Besides, access to prenatal testing usually 
involves specialized professionals in UCLA 
Medical Center. Genetic counselors are in each 
clinical department. Genetic counseling was 
available for pregnant women and their families 
when they needed it. Genetic counselors also 
could order prenatal screenings or invasive 
tests. Results were disclosed by the healthcare 
professional who ordered it. In most normal 
cases, genetic counselors informed patients by 
e-mail or telephone instantly. In Japan, there are 
226 certified genetic counselors as of 201714） and 
most of them belong to a limited number of 
larger hospitals. Therefore, pregnant women 
who wish for a consultation with a genetic 
counselor need to go to the nearest hospital 
where a genetic counselor is available. A first 
difference between the USA and Japan is that 
genetic counselors were rarely involved before 
amniocentesis in Japan６）． Most information 
about the invasive diagnosis was provided by 
local doctors６）． Another different point was 
that Japanese nurses and genetic counselors are 
unable to order tests and communicate their 
results without a doctor’s prescription. 
３．Diversity‌of‌ethnic‌and‌socioeconomic‌
groups
　In the USA, society is composed of various 
ethnic groups and healthcare providers need to 
consider each patient’s background. A Video 
Tele-Interpretation system was officially used 
for non-English speakers at no cost. This is a 
translation and interpretation system using the 
TV phone, available through partnership with 
the healthcare interpreter network. It allows 
face-to-face interaction ensuring high quality 
and timely patient care15）． To obtain official 
informed consent, the system must be used by 
n on -Eng l i s h  s p e ak e r s  s o  a s  t o  a v o i d 
misunderstanding. In California, this system is 
used within 30 hospitals15）． In Japan, hospitals 
have various ways to provide translational 
services. Standardized translational services are 
rare and generally provided by volunteer or 
patients’ families. 
　As for the cost, medical care including 
prenatal testing for low income patients was 
fully covered by Medi-Cal in California７）10）． On 
the other hand, all prenatal screenings and 
千葉大学大学院看護学研究科紀要　第41号
−78−
invasive procedures are not covered by 
insurance in Japan. Therefore, low income 
patients cannot undergo expensive prenatal 
testing.
　As for  chromosome ana lys is ,  carr ier 
screenings, such as for thalassemia, cystic 
fibrosis, sickle cell or other genetic diseases are 
performed in the USA more than in Japan. The 
purpose of carrier screening is to screen one or 
few genetic variants in targeted populations. In 
the USA, the number of fetal carrier screening 
during pregnancy is increasing16）． Genetic 
counselors order them and target specific 
conditions depending on patient’s race because 
the risk of carrying the diseases is different 
according to ethnicity. In Japan, the main 
reasons to undergo amniocentesis are advanced 
maternal age which accounts for over half of 
the procedures, abnormal results of maternal 
serum screening, and ultrasound findings17）． 
Because Japan is a mostly mono racial nation, 
and the Japanese population does not usually 
carry the conditions targeted by carrier 
screenings, these screening are not common in 
general amniocenteses.
Ⅲ Discussion
　In UCLA Medical Center, a large number of 
p r egnan t  women  underwen t  p r ena t a l 
screen ings ,  and spec ia l i zed hea l thcare 
professions facilitated women’s decision-making 
regarding prenatal testing. 
　From the point of view of historical difference, 
ACOG recommended not only screening tests 
but also invasive diagnostic testing to be 
available to all women regardless of maternal 
age in 2007７）８）． Consequently, the California 
State introduced the prenatal screening 
program. On the other hand, JSOG and the 
expert  commit tee  d id  not  support  the 
implementation of prenatal testing. 
　Regarding the termination of pregnancy, the 
US Supreme Court confirmed that women’s 
right to choose an abortion was protected by 
the US constitution in 1973 （Roe v. Wade）18）． 
In Japan ,  the  Eugen ic  Protect ion  Law 
established in 1948 to prevent the birth of 
inferior descendants was changed to the 
Maternal Protection Law in 1996 to protect the 
l i v e s  and  hea l t h  o f  p r egnan t  women . 
Organizations advocating for handicapped 
persons took the lead against the eugenic19）． 
According to the Maternal Protection Law, 
abortion is possible in case of pregnancy 
resulting from rape or when the pregnancy 
may significantly damage the woman’s health or 
cause her distress for economic reason. 
Abortion due to fetal abnormalities is not 
included in the conditions covered by the law. 
Nishiyama et al .  mentioned two reasons 
deterring pregnant women from receiving 
prenatal testing: one is a 1999 statement by the 
expert committee and JSOG not recommending 
prenatal screening, and another is the absence 
of legal permit for abortions due to fetal 
abnormalities６）． In addition, some disability 
organizations feel that aborting fetuses for fetal 
abnormalities may be similar to eugenics, owing 
to the connection between the Maternal 
Protection Law and to the Eugenic Protection 
Law in the past. 
　Tsai et al. showed that cultural factors such 
as lack of available resources （medical support, 
financial support, or emotional support），social 
pressure and stigma influenced attitude toward 
prenatal testing and abortion among the Asian 
population20）． Therefore, more individually 
tailored support is needed for autonomous 
decision-making regarding prenatal testing. 
There is also possibility of unequal access to 
genetic counseling and prenatal testing due to 
its high cost and availability in Japan. Only 
wealthy families can access prenatal tests, in 
the present situation. Furthermore, limited 
recognition of the importance of genetic 
counseling among obstetric professionals is a 
concern in Japan６） as women do not have the 
means to informed decision-making. At present 
prenatal screening is not recommended, 
however it is increasingly demanded by 
Japanese pregnant women３） and has potential 
to expand the spectrum of detectable conditions 
thanks to recent technological advances16）21）． 
Expanded carr ier  screening a l lows for 
identification of a greater number of genetic 
changes and conditions without limitation to 
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